Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
J Neurosci
2005 Jan 19;253:732-6. doi: 10.1523/JNEUROSCI.4065-04.2005.
Show Gene links
Show Anatomy links
A uniquely selective inhibitor of the mammalian fetal neuromuscular nicotinic acetylcholine receptor.
Teichert RW
,
Rivier J
,
Torres J
,
Dykert J
,
Miller C
,
Olivera BM
.
???displayArticle.abstract???
We have purified and characterized a novel conotoxin from the venom of Conus obscurus, which has the unique property of selectively and potently inhibiting the fetal form of the mammalian neuromuscular nicotinic acetylcholine receptor (nAChR) (alpha1beta1gammadelta-subunits). Although this conotoxin, alphaA-conotoxin OIVB (alphaA-OIVB), is a high-affinity antagonist (IC50 of 56 nm) of the fetal muscle nAChR, it has >1800-fold lower affinity for the adult muscle nAChR (alpha1beta1epsilondelta-subunits) and virtually no inhibitory activity at a high concentration on various neuronal nAChRs (IC50 > 100 microm in all cases). The peptide (amino acid sequence, CCGVONAACPOCVCNKTCG), with three disulfide bonds, has been chemically synthesized in a biologically active form. Although the neuromuscular nAChRs are perhaps the most extensively characterized of the receptors/ion channels of the nervous system, the precise physiological roles of the fetal form of the muscle nAChR are essentially unknown.alphaA-OIVB is a potentially important tool for delineating the functional roles ofalpha1beta1gammadelta receptors in normal development, as well as in various adult tissues and in pathological states. In addition to its potential as a research tool, alphaA-OIVB may have some direct biomedical applications.
Blount,
Molecular basis of the two nonequivalent ligand binding sites of the muscle nicotinic acetylcholine receptor.
1989, Pubmed
Blount,
Molecular basis of the two nonequivalent ligand binding sites of the muscle nicotinic acetylcholine receptor.
1989,
Pubmed
Bren,
Identification of residues in the adult nicotinic acetylcholine receptor that confer selectivity for curariform antagonists.
1997,
Pubmed
Cartier,
A new alpha-conotoxin which targets alpha3beta2 nicotinic acetylcholine receptors.
1996,
Pubmed
,
Xenbase
CHANG,
ISOLATION OF NEUROTOXINS FROM THE VENOM OF BUNGARUS MULTICINCTUS AND THEIR MODES OF NEUROMUSCULAR BLOCKING ACTION.
1963,
Pubmed
Changeux,
The functional architecture of the acetylcholine nicotinic receptor explored by affinity labelling and site-directed mutagenesis.
1992,
Pubmed
ELLMAN,
Tissue sulfhydryl groups.
1959,
Pubmed
Gattenloehner,
A comparison of MyoD1 and fetal acetylcholine receptor expression in childhood tumors and normal tissues: implications for the molecular diagnosis of minimal disease in rhabdomyosarcomas.
1999,
Pubmed
Gattenloehner,
The fetal form of the acetylcholine receptor distinguishes rhabdomyosarcomas from other childhood tumors.
1998,
Pubmed
Gattenlöhner,
Expression of foetal type acetylcholine receptor is restricted to type 1 muscle fibres in human neuromuscular disorders.
2002,
Pubmed
Groebe,
alpha-Conotoxins selectively inhibit one of the two acetylcholine binding sites of nicotinic receptors.
1995,
Pubmed
Gu,
Characterization of acetylcholine receptor subunits in developing and in denervated mammalian muscle.
1988,
Pubmed
Hopkins,
A new family of Conus peptides targeted to the nicotinic acetylcholine receptor.
1995,
Pubmed
Horton,
The 'embryonic' gamma subunit of the nicotinic acetylcholine receptor is expressed in adult extraocular muscle.
1993,
Pubmed
Jacobsen,
Differential targeting of nicotinic acetylcholine receptors by novel alphaA-conotoxins.
1997,
Pubmed
,
Xenbase
Jones,
The nicotinic acetylcholine receptor gene family of the pufferfish, Fugu rubripes.
2003,
Pubmed
Marx,
Proteins with epitopes of the acetylcholine receptor in epithelial cell cultures of thymomas in myasthenia gravis.
1989,
Pubmed
McArdle,
Waglerin-1 selectively blocks the epsilon form of the muscle nicotinic acetylcholine receptor.
1999,
Pubmed
Miller,
Peptide chemistry: development of high performance liquid chromatography and capillary zone electrophoresis.
1996,
Pubmed
Miller,
Analysis of synthetic peptides by capillary zone electrophoresis in organic/aqueous buffers.
1998,
Pubmed
Mishina,
Molecular distinction between fetal and adult forms of muscle acetylcholine receptor.
,
Pubmed
,
Xenbase
Navaneetham,
Human thymuses express incomplete sets of muscle acetylcholine receptor subunit transcripts that seldom include the delta subunit.
2001,
Pubmed
Osaka,
Subunit interface selectivity of the alpha-neurotoxins for the nicotinic acetylcholine receptor.
1999,
Pubmed
Sine,
Molecular dissection of subunit interfaces in the acetylcholine receptor: identification of determinants of alpha-conotoxin M1 selectivity.
1995,
Pubmed
Sine,
Molecular dissection of subunit interfaces in the acetylcholine receptor: identification of residues that determine curare selectivity.
1993,
Pubmed
Teichert,
AlphaA-Conotoxin OIVA defines a new alphaA-conotoxin subfamily of nicotinic acetylcholine receptor inhibitors.
2004,
Pubmed
Witzemann,
Developmental regulation of five subunit specific mRNAs encoding acetylcholine receptor subtypes in rat muscle.
1989,
Pubmed
Witzemann,
Differential regulation of muscle acetylcholine receptor gamma- and epsilon-subunit mRNAs.
1987,
Pubmed
